U.S. equity markets fought for gains Friday morning after a study found an experimental treatment reduced death in COVID-19 patients.

U.S. equity markets fought for gains Friday morning after a study found an experimental treatment reduced death in COVID-19 patients. The Dow Jones Industrial Average rose 19 points, or 0.07 percent, in the opening minutes of trading while the S&P 500 added 0.02 percent. The Nasdaq Composite seesawed between losses and gains after booking its 26th record-high close of the year on Thursday. In healthcare stocks, a Phase 3 study found Gilead Sciences Inc.'s experimental treatment remdesivir was associated with a 62 percent reduction in the risk of death in COVID-19 patients. On the same front, BioNTech CEO Dr. Ugur Sahin told The Wall Street Journal his company’s experimental COVID-19 vaccine, being developed with Pfizer Inc., will be ready for regulatory approval by the end of the year.

For more news, please go to FoxBusiness.com and watch Fox Business Network.

More NewslettersUnsubscribePrivacy PolicyContact Us

©2020 Fox News Network, LLC. 1211 Avenue of the Americas, New York, NY, 10036. All Rights Reserved. Privacy Policy

Fox Business never sends unsolicited email. You received this email because you requested a subscription to Fox Business Breaking News Alerts from FoxBusiness.com